Germany Precision Oncology Market Size & Outlook
Germany precision oncology market, 2018-2030 (US$M)
Related Markets
Germany precision oncology market highlights
- The Germany precision oncology market generated a revenue of USD 5,245.1 million in 2024 and is expected to reach USD 9,022.6 million by 2030.
- The Germany market is expected to grow at a CAGR of 9.5% from 2025 to 2030.
- In terms of segment, therapeutics was the largest revenue generating product in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Precision oncology market data book summary
| Market revenue in 2024 | USD 5,245.1 million |
| Market revenue in 2030 | USD 9,022.6 million |
| Growth rate | 9.5% (CAGR from 2025 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Thermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics |
Other key industry trends
- In terms of revenue, Germany accounted for 4.5% of the global precision oncology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK precision oncology market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 8,891.1 million by 2030.
Therapeutics was the largest segment with a revenue share of 77.97% in 2024. Horizon Databook has segmented the Germany precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The Germany precision oncology market is projected to expand at a significant CAGR during the forecast period. The country's strong emphasis on personalized medicine and its comprehensive healthcare infrastructure, which supports the adoption of innovative cancer treatments, is one of the key market drivers.
Germany is a leader in implementing genomic profiling and molecular diagnostics, which are integral to precision oncology. In addition, Germany’s extensive network of academic institutions and research organizations, such as the German Cancer Research Center, plays a crucial role in advancing the development of precision oncology therapies, further driving the market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Precision Oncology Market Scope
Precision Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany precision oncology market size, by cancer, 2018-2030 (US$M)
Germany Precision Oncology Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
